Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Garris, Christopher S., Arlauckas, Sean P., Kohler, Rainer H., Trefny, Marcel P., Garren, Seth, Piot, Cécile, Engblom, Camilla, Pfirschke, Christina +15 more·2018·Immunity

DOI 10.1016/j.immuni.2018.09.024

Cited by (970)

Items 701–800 of 970

Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinoma
Karen J. Scott, Emma J. West, Rebecca J. Brownlie, Fay Ismail, Christy Ralph, Thomas Heineman, Matt C. Coffey, Alan A. Melcher, Alison Taylor, Salvatore Papa et al. · 2026 · International Journal of Cancer
Dendritic Cell‐T Cell Crosstalk Mediated Cancer Immunotherapy
Y. Cai, Jiameng Chen, Yaping Li · 2026 · Exploration
First-in-human phase 1/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via intratumoral (IT) injection as monotherapy in advanced solid tumors, including recurrent or metastatic HNSCC
D M Ji, Wenmin Fu, Yonghong Liu, Weina Shen, Muyu Kuang, Zhouyu Ning, Youzhou Sang, Guangliang Chen, Jian Zhang, Zijie Zhou et al. · 2026 · BMC Medicine
Acquired resistance of cancer therapies: Mechanisms and perspectives
Manli Wang, Xiaoqian Zhai, Jiayao Li, Jiale Chen, Xiyue Gai, Xunxi Liu, Yu Liu, Qinghua Zhou, Chong Chen · 2026 · Chinese Medical Journal
Leveraging cDC1 biology and function for enhanced immunotherapy
Ross W. Ward, Uddipan Kar, Sreekumar Balan, Nina Bhardwaj · 2026 · The Journal of Experimental Medicine
Ferroptosis heterogeneity within the tumor microenvironment revealed a genetic blueprint of breast cancer
Ziran Qiu, Chongwen Deng, Fuyin Zhou, Yuan Chen, Xinliang Chen, Xinyu Liu, Chunhua Ye, Na Jin · 2024 · Environmental Toxicology
Multivalent ionizable lipid-polypeptides for tumor-confined mRNA transfection
Xiaofei Zhao, Yueyue Zhang, Xin Wang, Zi-Ming Fu, Zhiyuan Zhong, Chao Deng · 2025 · Bioactive Materials
Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma
Athanasios Seretis, Lukas Amon, Christoph H. Tripp, Giuseppe Cappellano, Florian Hornsteiner, Sophie Marie Dieckmann, Janine Vierthaler, Daniela Ortner, Markus Kanduth, Rita Steindl et al. · 2025 · Vaccines
Intravital Imaging of Immune Responses in the Cancer Microenvironment
Hiroki Hirao, Masaki Honda, Masahiro Tomita, Lianbo Li, Ahmad Adawy, Weijie Xue, Taizo Hibi · 2025 · Cancer Medicine
Harnessing the power of tumor-draining lymph nodes: unveiling predictive biomarkers for immune checkpoint inhibitor
Zihan Chen, Jiangnan Yu, Guo Zhikun, Shuxian Chen, Yina Li, Qian Zhou, Lei Wang · 2025 · Exploration of Targeted Anti-tumor Therapy
Emerging IO checkpoints in gastrointestinal oncology
Alireza Tojjari, Anwaar Saeed, Ludimila L. Cavalcante · 2025 · Frontiers in Immunology
Predicting pathological response of resectable esophageal squamous cell carcinoma to neoadjuvant anti-PD-1 with chemotherapy using serum inflammation indexes
Peng Song, Zhiyuan Yao, Shuai Song, Zengjin Wen, Xiao Sun, Changlei Li, Huansong Yang, Wenjie Jiao, Yong Cui, Dong Chang · 2025 · Scientific Reports
CAR‐DC combined with CAR‐T therapy for relapsed/refractory acute myeloid leukaemia: Research progress and future perspectives
Rui Zhang, Jinlin Zhang, Hongkai Zhang, Mingfeng Zhao · 2025 · Clinical and Translational Medicine
In situ release of IL-2/IL-12 from SiO 2 -engineered dendritic cells for synergistic immunotherapy
Rong Xu, Kaijing Liu, Xiaoli Wang, Chuangnian Zhang, Yajing Zhang, Jing Yang · 2022 · Nanoscale
Ranitidine as an adjuvant regulates macrophage polarization and activates CTLs through the PI3K-Akt2 signaling pathway
Chenglin Li, Shuang Wang, Xiaoran Ma, Tiantian Wang, Ran Lu, Xihui Jia, Zhe Leng, Xiaowen Kong, Jinyu Zhang, Ling Li · 2023 · International Immunopharmacology
Develop a PD-1-blockade peptide to reinvigorate T-cell activity and inhibit tumor progress
Yingzhou Qin, Xiangzhou Meng, Lin Li, Cuijuan Liu, Fan Gao, Xin Yuan, Ying Huang, Yimin Zhu · 2023 · European Journal of Pharmacology
Developing synthetic tools to decipher the tumor–immune interactome
Orr-El Weizman, Sophia Luyten, Peiwen Lu, Eric Song, Kai Qin, Darius Mostaghimi, Aaron M. Ring, Akiko Iwasaki · 2023 · Proceedings of the National Academy of Sciences
Head-to-Head Comparison of CCN4, DNMT3A, PTPN11, and SPARC as Suppressors of Anti-tumor Immunity
Anika Pirkey, Wentao Deng, Danielle Norman, Atefeh P. Razazan, David J. Klinke · 2023 · Cellular and Molecular Bioengineering
Biopterin metabolism and nitric oxide recoupling in cancer
Gene Chatman Clark, Alan Lai, Aashri Agarwal, Zheng Liu, Xiangyang Wang · 2024 · Frontiers in Oncology
Fluorinated Chitosan‐Mediated Transepithelial Delivery of Intravesical Dual‐Drug Immunotherapeutic for Bladder Cancer Therapy
Lida Feng, Guixiao Huang, Qifang Lei, Mingkang Liang, Dashi Deng, Xiaocen Liu, Chenfan Kong, Chenchen Li, Xiyang Tan, Guangzhi Li et al. · 2024 · Advanced Therapeutics
Boosting Dendritic Cell Function in Cancer
Evangelos Giampazolias · 2025 · Cancer Medicine
Role of Periostin Expression in Canine Osteosarcoma Biology and Clinical Outcome
Lauren Alfino, Kai C. Wilczewski‐Shirai, Kathryn E. Cronise, Jonathan W. Coy, Kristina E. Glapa, E. J. Ehrhart, Joseph B. Charles, Dawn L. Duval, Daniel P. Regan · 2021 · Veterinary Pathology
Cell–cell communication networks in tissue: Toward quantitatively linking structure with function
Gaurav Luthria, Douglas A. Lauffenburger, Miles Aaron Miller · 2021 · Current Opinion in Systems Biology
Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
Zhaobin He, Cheng Peng, Tianen Li, Jie Li · 2022 · Frontiers in Genetics
PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness
Xiang-Yu Chen, Yao Lin, S. Yue, Yang Yang, Xiaofan Yang, Jun-Jian He, Lei-Qiong Gao, Zhi-Rong Li, Li Hu, Jian-Fang Tang et al. · 2023 · Vaccine
Antitumor activity of pegylated human interferon β as monotherapy or in combination with immune checkpoint inhibitors via tumor growth inhibition and dendritic cell activation
Rui Wang, Tao Zhang, Yuan Lu, Yalong Lin, Shuyuan Kou, Xuefeng Li, Yang Wang, Liangzhi Xie · 2023 · Cellular Immunology
PD‐L1 positive macrophages were increased in a case of pembrolizumab‐induced bullous pemphigoid
Kozo Nakai, Yasunori Sato, Shoji Kubo, Daisuke Tsuruta · 2021 · The Journal of Dermatology
Association Between FSIP2 Mutation and an Improved Efficacy of Immune Checkpoint Inhibitors in Patients With Skin Cutaneous Melanoma
Haoxuan Ying, Anqi Lin, Junyi Liang, Jian Zhang, Peng Luo · 2021 · Frontiers in Molecular Biosciences
Peripheral Circulating CD45RA−FOXP3hi T Regulatory (TReg) II Cells Provide a Window into the Activity of Intratumoral TReg Cells
Sara Isabel Pai, Francesco Maria Marincola · 2019 · Trends in cancer
Combining chemotherapy and autologous peptide‐pulsed dendritic cells provides survival benefit in stage IV melanoma patients
Klaus Eisendle, Georg Weinlich, Susanne Ebner, Markus Forstner, Daniela Reider, Claudia Zelle‐Rieser, Christoph H. Tripp, Peter O Fritsch, Patrizia Stoitzner, Nikolaus Romani et al. · 2020 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
PD-1 blockade-driven anti-tumor CD8 + T cell immunity requires XCR1 + dendritic cells
Tianyang Mao, Eric Song, Akiko Iwasaki · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression
Michael P. Plebanek, Yue Xue, Y‐Van Nguyen, Nicholas C. DeVito, Xueying Wang, Alisha Holtzhausen, Georgia Marie Beasley, Nagendra Sastry Yarla, Bala Thievanthiran, Brent Allen Hanks · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Future of Dendritic Cell–Based Approaches in Pancreatic Cancer
Ashwin Somasundaram, Jen Jen Yeh · 2024 · Journal of Clinical Oncology
Inflammatory arthritis immune related adverse events represent a unique autoimmune disease entity primarily driven by T cells, but likely not autoantibodies
Xingxing Zhu, Yue Yu, Yanfeng Li, Panwen Wang, Ying Li, Chantal E. McCabe, Shiju Chen, Hannah E. Langenfeld, Andrew C. Hanson, Brenna E. Sharp et al. · 2025 · medRxiv
Scupa: single-cell unified polarization assessment of immune cells using the single-cell foundation model
Wendao Liu, Zhongming Zhao · 2025 · Bioinformatics
Immune-checkpoint inhibitor resistance in patients with cancer
Luis Cabezón‐Gutiérrez, Sara Custodio‐Cabello, Magda Palka-Kotlowska, Beatriz Chacón-Ovejero, Vilma Pacheco-Barcía · 2025 · Exploration of Immunology
Immune archetypes TIME classification system for nasopharyngeal carcinoma: A new direction for precision immunotherapy
Fei Lu, Xueqi Bai, Zongjing Lv, Wenling Zhang · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Single-cell atlas of the tumor immune microenvironment across syngeneic murine models
Jia Wang, Bin Jiang, Minjuan Deng, Han Yan, Pei Zhang, Wei Jin, Zhirong Shen · 2025 · Frontiers in Immunology
Oral microbiota-responsive ZIF nanoplatform via double-layer glycans modified combined with PD-1 inhibitor for treatment of microsatellite-stable colorectal cancer
Yeyang Sun, Xietao Ye, Lin Yang, Shuo Dong, Chen Chen, Yani Wang, Jianan Qiao, Congyan Liu, Yuping Liu, Yan Chen · 2025 · Materials Today Bio
Cascade-responsive hydrogen sulfide-releasing nanoplatform for synergistic tumor photothermal-immunotherapy
Junhong Ling, Zhen Liu, Hang Wu, Yuanjie Jin, Yani He, Nan Wang, Xiao–kun Ouyang · 2026 · Journal of Colloid and Interface Science
Inflammatory arthritis irAE may represent a unique autoimmune disease primarily driven by T cells but likely not autoantibodies
Xingxing Zhu, Yue Yu, Yanfeng Li, Panwen Wang, Ying Li, Chantal McCabe, S. Chen, Hannah E. Langenfeld, Andrew C. Hanson, Brenna Sharp et al. · 2026 · Science Advances
Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models
Akash Gupta, R. Das, Kaelan Reed, T. Jeon, Q. T. C. Nguyen, Arnab Rudra, X. Ge, S. Trongjit, Y. S. Vanrobaeys, Róbert Langer et al. · 2026 · Nature Biotechnology
Oat-β-glucan potentiates anti-PD-1 efficacy through Faecalibacterium prausnitzii-derived butyrate and indole-3-propionic acid
Shuaishuai Yang, Haojie Lu, Min Jin, Wei Pei, Zhen Wang, Jingjing Ni, Yuting Shi, Shuo Zhang, Yiting Li, C Li et al. · 2026 · Cell Host & Microbe
Tumor–immune metabolic tug-of-war: from immune escape to targeting metabolic rewiring in cancer therapy
Beatrice Foglia, Jessica Nurcis, Marta Signorini, Stefania Cannito · 2026 · Frontiers in Cell and Developmental Biology
H3K18 lactylation drives CD8+ T cell exclusion and anti-PD-1 resistance in hepatocellular carcinoma
Jiang Zhu, Xinye Dai, Ting Luo, Qingbo Zhou, Xuping Feng, Chang Liu, Buzhe Zhang, Bangjie Yin, Pu Wu, Ruihan Luo et al. · 2026 · Cell Reports
CCR7+ activated dendritic cells are essential for spontaneous and immunotherapy-driven anti-tumor immunity
Maria A. Koufaki, Erin Richardson, Eduardo Bonavita, Richard Reeves, Agrin Moeini, Shih‐Chieh Chiang, Antonia Banyard, Massimo Russo, Charles H. Earnshaw, Charlotte R. Bell et al. · 2026 · Immunity
Immunemodulation and Cancer
Jinhong Liu, Jeffrey Jianhong Huang · 2023 · Springer eBooks
Pathological mechanisms and advances in neoadjuvant PD-1 blockade combined with chemotherapy for head and neck cancer
Yunjing Hou, Xinxin Yang, Hongxue Meng · 2024 · Holistic Integrative Oncology
Inhibiting HnRNP L-mediated alternative splicing of EIF4G1 counteracts immune checkpoint blockade resistance in Castration-resistant prostate Cancer
Xumin Zhou, Shilong Cheng, Zhongjie Chen, Jinming Zhang, Jiaqi Wang, Qiang Li, Xumin Zhou · 2024 · Neoplasia
Neoantigen Vaccines in Cancer Prevention
Abel Martel-Martel, Krishna M. Sinha, Eduardo Vilar · 2025 · The Cancer Journal
Harnessing dendritic cells as immunological bridges to potentiate mRNA cancer vaccines
Ruiying Wu, Huixin Li, Ziqin Li, Kai Hao, Huayu Tian · 2025 · Journal of Materials Chemistry B
A case report of microsatellite instability (MSI)-high, HER2 amplified pancreatic adenocarcinoma with central nervous system metastasis
Nicholas C. DeVito, Colm B. Kelleher, Kyle C. Strickland, James L. Abbruzzese, Carey K. Anders, Brent Allen Hanks, Jingquan Jia, Niharika B. Mettu, Michael A. Morse, Margot O’Neill et al. · 2021 · AME Case Reports
TRAIL produced by SAM-1-activated CD4+ and CD8+ subgroup T cells induces apoptosis in human tumor cells through upregulation of death receptors
Guojun Zhang, Mingkai Xu, Xiaoqing Zhang, Ling Ma, Huiwen Zhang · 2021 · Toxicology and Applied Pharmacology
Holarrhena pubescens Wall. ex G. Don Extracts Inhibit LPS-Irritated Oxidative Stress in Dendritic Cells
Yinyan Yin, Bangyue Zhou, Lirong Bai, Danni Feng, Tao Qin, Chunmei Li · 2022 · Applied Sciences
Immune checkpoint biology in health & disease: Immune checkpoint biology and autoimmunity in cancer patients
Pierre Van Mol, Elena Donders, Diether Lambrechts, Els Wauters · 2023 · International review of cytology
Role of Neoadjuvant Therapy Prior to Curative Resection in Hepatocellular Carcinoma
Zachary A Whitham, David Hsiehchen · 2023 · Surgical Oncology Clinics of North America
Hypoxia potentiated pro-angiogenic and anti-fibrotic effect of nanovesicles derived from human mesenchymal stem cells
Jiyu Hyun, Dae Won Yun, Soong Ho Um, Suk Ho Bhang · 2024 · Journal of Industrial and Engineering Chemistry
Heightened innate immune state induced by viral vector leads to enhanced response to challenge and prolongs malaria vaccine protection
Komi Gbédandé, Samad A. Ibitokou, Mark Joseph Endrino, George S. Yap, Michael G. Brown, Robin Stephens · 2024 · iScience
A Novel Polymersome Nanocarrier Promotes Anti‐Tumour Immunity by Improved Priming of CD8 + T Cells
Regine J. Dress, William W. Ho, Victor Chin Yong Ho, Jian Hang Lam, Fabien M. Décaillot, Gaurav Sinsinbar, Jenetta Soo, Gowshika Rengasamy, Amit Kumar Khan, Thomas Andrew Cornell et al. · 2025 · Immunology
Cytokine-driven cancer immune evasion mechanisms
Enrique Javier Arenas · 2025 · International review of cytology
Distinct Biomarker Profiles and TCR Sequence Diversity Characterize the Response to PD-L1 Blockade in a Mouse Melanoma Model
Rajaâ El Meskini, Devon Atkinson, Alan Kulaga, Abdalla Amr Abdelmaksoud, Michelle Gumprecht, Nathan Pate, Susana Hayes, Michael D. Oberst, Ian M. Kaplan, Patrick L. Raber et al. · 2021 · Molecular Cancer Research
The hipotises of the immune system's role in carcinogenesis
Y. K Slepov, M. A. Laushkin, Roman V. Deev · 2021 · Genes and Cells
Adaptive anti-tumor immunity is orchestrated by a population of CCL5-producing tissue-resident NK cells
Nicole Kirchhammer, Marcel P. Trefny, Marina Natoli, Dominik Brücher, Sheena N. Smith, Franziska Werner, Victoria Koch, David Schreiner, Ewelina Magdalena Bartoszek, Mélanie Buchi et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Single-cell transcriptomics reveal distinct subsets of activated dendritic cells in the tumor microenvironment
Tsun Ki Jerrick To, Samir Devalaraja, Ian Wesley Folkert, Li Zhai, Graham P. Lobel, Malay Haldar · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Eradication of tumors with pre-existing antigenic heterogeneity by vaccine-mediated co-engagement of CAR T and endogenous T-cells
Leyuan Ma, Duncan M. Morgan, Ina Sulkaj, Parisa Yousefpour, Charles A. Whittaker, Wuhbet D. Abraham, Na Li, John Christopher Love, Darrell J. Irvine · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Wnt inhibition alleviates resistance to immune checkpoint blockade in glioblastoma
Rakesh K. Jain, Shanmugarajan Krishnan, Somin Lee, Zohreh Amoozgar, Sonu Subudhi, Ashwin Srinivasan Kumar, Jessica M. Posada, Neal Ian Lindeman, Pin‐Ji Lei, Mark A. Duquette et al. · 2023 · Research Square
Flt3L enhances clonal diversification and selective expansion of intratumoral CD8+ T cells while differentiating into effector-like cells
Dongmin Chun, Jiyeon Park, Seulgi Lee, Hyo Jae Kim, Jong-Eun Park, Suk‐Jo Kang · 2024 · Cell Reports
Preclinical study of TLR stimulation combined PD-1 antibody enhance the therapeutic effect of microwave ablation on NSCLC
Ying Yu, Fu Niu, Bo Sun, Shusen Zhang, Zhigang Cai · 2024 · Clinical & Translational Oncology
An Immunomodulating Peptide with Potential to Promote Anticancer Immunity Without Compromising Immune Tolerance
Michael Agrez, Christopher Chandler, Amanda L. Johnson, Marlena Sorensen, Kirstin Cho, Stephen Parker, Benjamin J. Blyth, Darryl G. Turner, Justyna Rzepecka, Gavin Knox et al. · 2025 · Biomedicines
Dendritic Cells at the Center of Reactive Tumor Immunity
Lomax F. Pass, Matthew F. Krummel · 2025 · Immunological Reviews
Radiation regulates the expression of HLA-I in esophageal squamous cell carcinoma through interferon-γ
Shanshan Shao, Chi Pan, Qingtao Ni, Junxing Huang · 2025 · Scientific Reports
A KRASG12V-targeted bispecific T cell engager promotes immunity against colorectal solid tumor
Nhan Huynh, Thu-My Thi Nguyen, Ngoc Thi Bui, Hoai‐Nghia Nguyen, Cuong Thach Nguyen · 2025 · Molecular Therapy Oncology
Dual blockades of TIM-3 and PD-1 effectively prevent hyper-progression and enhance the efficacy of anti-PD-1 therapy in high-grade serous ovarian cancer
Jie Li, Ying Zhou, Yahan Song, Geyang Dai, Xi Li, Yue Sun, Jing Wang, Rui Wei, Fei Li, Ling Xi · 2025 · Cell Death and Disease
Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1
Gary Middleton, Charlotte Gaskell, Joshua Savage, John A. Bridgewater, Paul J. Ross, Mark P. Saunders, Daniel H. Palmer, Ruth Plummer, Sally Clive, Vicky M. Coyle et al. · 2025 · Journal for ImmunoTherapy of Cancer
Demountable quinoidal semiconductor nanobackpacks modulate neuro-immune for amplifying second near-infrared photoimmunotherapy of breast cancer
Yijing Zhang, Guangkun Song, Gaoli Niu, Ruiyan Li, Xue Yuan, Nana Ran, Yulu Hu, Tianze Du, Yongsheng Chen, Yong Kang et al. · 2026 · Materials Today
Advancing immunotherapy via multiple immune cells co-engagement
Han Li, Yuxuan Zhang, Qiuyang Wei, Qimeng Sun, Feng Lin, Peng R. Chen · 2026 · Frontiers in Immunology
Impact of Prior mRNA COVID-19 Vaccination on PFS2 in NSCLC Patients Receiving Second-Line Immune Checkpoint Inhibitors: A Real-World Analysis
Selahattin Çelik, Engin Eren Kavak, Esra Zeynelgil, Gökşen İnanç İmamoğlu, İsmail Dilli, Salih Karatlı, Mehmetcan Atak, Mustafa Altınbaş, Tülay Eren · 2026 · Journal of Clinical Medicine
An epigenetically enhanced whole-cell vaccine in a stimulatory hydrogel for robust antitumor immunity
Xiaodi Li, Xiaoqing Zong, Pengfei Yuan, Xiaodie Yan, Caiqi Yang, Xinjie Chen, Siying Wei, Yaoqi Wen, Jingru Du, Xiang liu et al. · 2026 · Biomaterials
Role of innate immunity in the development of cancer immunotherapy immune-mediated adverse events
Álvaro Sierra-Salazar, Yatzil Reyna-Juárez, Beatriz Alcalá‐Carmona, Rodrigo Quintana-Tenorio, Jennifer Tiaré Balderas-Miranda, Johan Camacho-Pérez, Jiram José Torres-Ruiz · 2026 · Frontiers in Immunology
Bridging clinical gaps in personalized cancer neoantigen vaccines
Karam Khaddour, Patrick Alexander Ott · 2026 · Cancer Cell
Food-Derived Limosilactobacillus fermentum GR-3 Enhances Anti–PD-1 Immunotherapy Efficacy
Wei Xiang, Qi Yang, Jing Ji, Hui Qiao, Aman Khan, El‐Sayed Salama, Chunlan Mao, Ying Wu, Xiangkai Li · 2026 · Probiotics and Antimicrobial Proteins
Molecular mechanisms and recent advances in cellular senescence
Ashaq Hussain, Marc Tatar, Rujun Gong · 2026 · Cell & Bioscience
Dendritic cell diversity and dysfunction in cancer: implications for immunotherapy and therapeutic targeting
Rong Wang, Yi Chen, Yan-fen Fang · 2026 · Acta Pharmacologica Sinica
Longitudinal gut microbiome dynamics during immunotherapy identify microbial features of clinical benefit in advanced primary liver cancer.
Zhen-Wei Qian, Jie Han, Beile Lyu, Aizier Ainiwaer, Qian-Cheng Zhao, Shuai Wang, Jia-Min Cheng, Yinyin Li, Ying Sun, Xian-Nian Zhang et al. · 2026 · Gut
Contextual control of CD8+ T cell priming by dendritic cell subsets in tumor and inflammatory microenvironments
Victoria P. Schuster, Naomi Berkowitz, Kasidy Brown, Catherine Rousculp, Valentina Laverde, Julia R Unsworth, Megan K. Ruhland · 2026 · Cell Reports
And Now for Something Completely Different: Immunotherapy Beyond Checkpoints in Melanoma
Isabella Claudia Glitza, Stephanie L. Goff, Merrick I. Ross, Kim Allyson Margolin · 2020 · American Society of Clinical Oncology Educational Book
Dendritic Cell Differentiation from Human Induced Pluripotent Stem Cells: Challenges and Progress
Nélio Alessandro de Jesus Oliveira, Handan Sevim · 2022 · Stem Cells and Development
Something old, something new: The marriage of PD-1 and IL-2
Brendan L. Horton, Stefani Spranger · 2023 · Immunity
Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
Jun Qiu, Haoyun Wang, Xin Lv, Lipeng Mao, Junyan Huang, Tao Hao, Junliang Li, Shuo Qi, Guodong Chen, Haiping Jiang · 2023 · Open Life Sciences
Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activation
Jie Shao, Kai Xin, Zhaoye Qian, Fangcen Liu, Lin Li, Junmeng Zhu, Qin Liu, Manman Tian, Rutian Li · 2024 · Human Vaccines & Immunotherapeutics
Pharmacokinetics, pharmacodynamics, and safety of GS ‐3583, a FLT3 agonist Fc fusion protein, from single‐ascending‐dose phase I study in healthy participants
Anees M. Dauki, Nishanthan Rajakumaraswamy, Torsten Trowe, Winnie Weng, Kai‐Wen Lin, Emon Elboudjwarej, Ann Qin, Christian Schwabe, Michelle R. Kuhné, Ahmed A. Othman · 2024 · Clinical and Translational Science
Platycodin D reduces PD ‐ L1 levels by inhibiting LXR ‐β activity and combines with nintedanib to enhance the tumor‐killing effect of T cells
Jin Lei, Xue‐Wei Cao, Pengfei Li, Jian Zhao, Fujun Wang · 2024 · FEBS Letters
Monitoring antigen-specific cellular immune response using an RT-ddPCR-based assay for IFN-γ gene expression
Yan‐Shan Dai, Adithi Adusumilli, Faiza Adeel, Alexander T. Kozhich, Vibha Jawa · 2024 · Journal of Pharmaceutical Sciences
Sex-Related Differences in the Immune System Drive Differential Responses to Anti-PD-1 Immunotherapy
Sonja Cotra, Mohammad Kohandel, Michelle Przedborski · 2024 · Biomolecules
Regulatory T cells in the tumor microenvironment display a unique chromatin accessibility profile
Rebekah Dadey, Jian Cui, Dhivyaa Rajasundaram, Hiroshi Yano, Chang Liu, Jonathan A. Cohen, Andrew W. Liu, Daniel H. Kaplan, Creg J. Workman, Dario A.A. Vignali · 2025 · ImmunoHorizons
Comprehensive single-cell analysis of triple-negative breast cancer based on cDC1 immune-related genes: prognostic model construction and immunotherapy potential
Linan Huang, Yiran Liu, Yulin Shi, Qi Sun, Huayao Li, Changgang Sun · 2025 · Discover Oncology
Molecular insights and treatment innovations: Advancing outcomes in acute myeloid leukemia with myelodysplasia‑related changes (Review)
Hong Qiu, Chaowei Zhang, Xiaochen Ma, Ying Li · 2025 · Oncology Reports
Unveiling rifampin’s impact on OSCC lysate-pulsed DCs: From inflammatory to anti-inflammatory landscape
Amirhossein Hatami‐Sadr, Farid Ghorbaninezhad, Bahar Naseri, Mahya Ahmadpour Youshanlui, Sahand Eslami, Javad Masoumi, Adileh Shirmohammadi, Seyed Emad Seyedgholamisharabiani, Behzad Baradaran · 2025 · Tissue and Cell
Cancer Resistance to Immunotherapy
Rita Khoury, Annoir Shayya, Cendrella Bou Orm, Osama Zein Deen, Hady Ghanem · 2025 · Immuno
Local therapy overcomes primary resistance to target-immunotherapy combination in unresectable hepatocellular carcinoma
Xiangqi Chen, Mingjian Piao, Zixiang Zhou, Shanshan Wang, Shuofeng Li, Nan Zhang, Boyu Sun, Kai Liu, Xu Yang, Xiaobo Yang et al. · 2025 · Cancer Immunology Immunotherapy